683 Capital Management LLC 13D and 13G filings for Eiger BioPharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:03 pm Sale | 2023-12-31 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | 683 Capital Management LLC | 70,000 4.700% | -33,833 (-32.58%) | Filing |
| 2023-02-14 2:23 pm Sale | 2022-12-31 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | 683 Capital Management LLC | 103,833 7.100% | -6,167 (-5.61%) | Filing |
| 2022-02-11 6:34 pm Purchase | 2021-12-31 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | 683 Capital Management LLC | 110,000 9.700% | 20,547 (+22.97%) | Filing |
| 2021-02-16 3:18 pm Purchase | 2020-12-31 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | 683 Capital Management LLC | 89,453 8.200% | 89,453 (New Position) | Filing |
| 2020-02-13 10:09 am Purchase | 2019-12-31 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | 683 Capital Management LLC | 61,667 7.600% | 7,982 (+14.87%) | Filing |